| CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
3.68% |
|
|
|
|
|
N/A |
0.00% |
43.58% |
34.55% |
|---|
| ALKS |
Alkermes plc |
0 |
3.65% |
|
|
|
|
|
N/A |
0.00% |
83.50% |
97.31% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
0 |
3.22% |
|
|
|
|
|
N/A |
0.00% |
41.26% |
9.66% |
|---|
| VRNA |
Verona Pharma plc |
0 |
3.01% |
|
|
|
|
|
N/A |
0.00% |
N/A |
2.73% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
0 |
2.77% |
|
|
|
|
|
N/A |
0.00% |
56.38% |
31.97% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
2.73% |
|
|
|
|
|
N/A |
0.00% |
83.89% |
48.55% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
0 |
2.71% |
|
|
|
|
|
N/A |
0.00% |
54.51% |
25.48% |
|---|
| MLTX |
MoonLake Immunotherapeutics |
0 |
2.62% |
|
|
|
|
|
N/A |
0.00% |
64.79% |
28.60% |
|---|
| XENE |
Xenon Pharmaceuticals Inc. |
0 |
2.30% |
|
|
|
|
|
N/A |
0.00% |
175.91% |
14.71% |
|---|
| DNLI |
Denali Therapeutics Inc. |
0 |
2.28% |
|
|
|
|
|
N/A |
0.00% |
84.98% |
21.44% |
|---|
| ZLAB |
Zai Lab Limited |
0 |
2.27% |
|
|
|
|
|
N/A |
0.00% |
66.90% |
18.81% |
|---|
| MRUS |
Merus N.V. |
0 |
2.25% |
|
|
|
|
|
N/A |
0.00% |
45.17% |
21.26% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
0 |
2.20% |
|
|
|
|
|
N/A |
0.00% |
935.57% |
55.59% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
2.18% |
|
|
|
|
|
N/A |
0.00% |
N/A |
37.30% |
|---|
| VCEL |
Vericel Corporation |
0 |
2.14% |
|
|
|
|
|
N/A |
0.00% |
61.40% |
75.54% |
|---|
| VERA |
Vera Therapeutics, Inc. |
0 |
2.09% |
|
|
|
|
|
N/A |
0.00% |
54.18% |
9.05% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
0 |
2.01% |
|
|
|
|
|
N/A |
0.00% |
72.21% |
7.21% |
|---|
| NAMS |
NewAmsterdam Pharma Company N.V. |
0 |
1.85% |
|
|
|
|
|
N/A |
0.00% |
79.42% |
17.60% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
1.80% |
|
|
|
|
|
N/A |
0.00% |
52.04% |
26.51% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
0 |
1.69% |
|
|
|
|
|
N/A |
0.00% |
N/A |
49.08% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
0 |
1.64% |
|
|
|
|
|
N/A |
0.00% |
68.01% |
33.13% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
0 |
1.58% |
|
|
|
|
|
N/A |
0.00% |
62.72% |
3.41% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
1.55% |
|
|
|
|
|
N/A |
0.00% |
73.26% |
43.94% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
0 |
1.53% |
|
|
|
|
|
N/A |
0.00% |
72.55% |
19.60% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
0 |
1.51% |
|
|
|
|
|
N/A |
0.00% |
108.78% |
30.63% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
0 |
1.48% |
|
|
|
|
|
N/A |
0.00% |
49.51% |
39.92% |
|---|
| IRON |
Disc Medicine, Inc. |
0 |
1.44% |
|
|
|
|
|
N/A |
0.00% |
58.45% |
31.10% |
|---|
| GLPG |
Galapagos NV |
0 |
1.41% |
|
|
|
|
|
N/A |
0.00% |
42.08% |
68.95% |
|---|
| MNKD |
MannKind Corporation |
0 |
1.41% |
|
|
|
|
|
N/A |
0.00% |
218.82% |
102.67% |
|---|
| NMRA |
Neumora Therapeutics, Inc. Common Stock |
0 |
1.40% |
|
|
|
|
|
N/A |
0.00% |
775.07% |
45.25% |
|---|
| CLDX |
Celldex Therapeutics, Inc. |
0 |
1.31% |
|
|
|
|
|
N/A |
0.00% |
95.48% |
57.89% |
|---|
| XNCR |
Xencor, Inc. |
0 |
1.30% |
|
|
|
|
|
N/A |
0.00% |
N/A |
30.50% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
1.22% |
|
|
|
|
|
N/A |
0.00% |
58.58% |
45.83% |
|---|
| VRDN |
Viridian Therapeutics, Inc. |
0 |
1.21% |
|
|
|
|
|
N/A |
0.00% |
1,701.86% |
16.12% |
|---|
| GPCR |
Structure Therapeutics Inc. |
0 |
1.19% |
|
|
|
|
|
N/A |
0.00% |
80.91% |
53.45% |
|---|
| IMCR |
Immunocore Holdings plc |
0 |
1.14% |
|
|
|
|
|
N/A |
0.00% |
57.61% |
32.73% |
|---|
| PRAX |
Praxis Precision Medicines, Inc. |
0 |
1.11% |
|
|
|
|
|
N/A |
0.00% |
159.65% |
67.98% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
0 |
1.07% |
|
|
|
|
|
N/A |
0.00% |
729.18% |
59.71% |
|---|
| AUPH |
Aurinia Pharmaceuticals Inc. |
0 |
1.03% |
|
|
|
|
|
N/A |
0.00% |
N/A |
34.25% |
|---|
| NVAX |
Novavax, Inc. |
0 |
1.00% |
|
|
|
|
|
N/A |
0.00% |
79.59% |
40.53% |
|---|
| DAWN |
Day One Biopharmaceuticals, Inc. |
0 |
0.99% |
|
|
|
|
|
N/A |
0.00% |
413.95% |
69.06% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
0.91% |
|
|
|
|
|
N/A |
0.00% |
143.78% |
47.93% |
|---|
| PHVS |
Pharvaris N.V. |
0 |
0.81% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
|---|
| VIR |
Vir Biotechnology, Inc. |
0 |
0.79% |
|
|
|
|
|
N/A |
0.00% |
284.44% |
45.91% |
|---|
| LQDA |
Liquidia Corporation |
0 |
0.76% |
|
|
|
|
|
N/A |
0.00% |
100.07% |
46.55% |
|---|
| AVXL |
Anavex Life Sciences Corp. |
0 |
0.73% |
|
|
|
|
|
N/A |
0.00% |
N/A |
33.68% |
|---|
| REPL |
Replimune Group, Inc. |
0 |
0.73% |
|
|
|
|
|
N/A |
0.00% |
171.37% |
72.93% |
|---|
| UPB |
Upstream Bio Inc. |
|
0.72% |
|
|
|
|
|
|
|
|
|
|---|
| AVBP |
ArriVent BioPharma, Inc. Common Stock |
0 |
0.71% |
|
|
|
|
|
N/A |
0.00% |
77.59% |
84.90% |
|---|
| NUVB |
Nuvation Bio Inc. |
0 |
0.69% |
|
|
|
|
|
N/A |
0.00% |
N/A |
15.75% |
|---|
| PRTA |
Prothena Corporation plc |
0 |
0.63% |
|
|
|
|
|
N/A |
0.00% |
127.84% |
26.21% |
|---|
| PLRX |
Pliant Therapeutics, Inc. |
0 |
0.61% |
|
|
|
|
|
N/A |
0.00% |
575.65% |
22.96% |
|---|
| ERAS |
Erasca, Inc. |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
251.14% |
37.12% |
|---|
| IRWD |
Ironwood Pharmaceuticals, Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
388.55% |
52.59% |
|---|
| RAPP |
Rapport Therapeutics Inc. |
|
0.53% |
|
|
|
|
|
|
|
|
|
|---|
| IMNM |
Immunome, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
90.59% |
36.11% |
|---|
| DNTH |
Dianthus Therapeutics, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
110.66% |
32.10% |
|---|
| CRGX |
CARGO Therapeutics, Inc. Common Stock |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
290.32% |
28.30% |
|---|
| KROS |
Keros Therapeutics, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
66.48% |
19.29% |
|---|
| CAPR |
Capricor Therapeutics, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
196.61% |
56.93% |
|---|
| MLYS |
Mineralys Therapeutics, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
N/A |
11.92% |
|---|
| MBX |
MBX Biosciences Inc. |
|
0.47% |
|
|
|
|
|
|
|
|
|
|---|
| AUTL |
Autolus Therapeutics plc |
0 |
0.46% |
|
|
|
|
|
N/A |
0.00% |
N/A |
22.22% |
|---|
| STOK |
Stoke Therapeutics, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
131.82% |
30.13% |
|---|
| FLGT |
Fulgent Genetics, Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
169.65% |
47.04% |
|---|
| ANNX |
Annexon, Inc. |
0 |
0.43% |
|
|
|
|
|
N/A |
0.00% |
169.34% |
19.64% |
|---|
| SVRA |
Savara Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
468.85% |
17.92% |
|---|
| TRML |
Tourmaline Bio, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
N/A |
36.85% |
|---|
| ATXS |
Astria Therapeutics, Inc. |
0 |
0.39% |
|
|
|
|
|
N/A |
0.00% |
122.72% |
28.97% |
|---|
| CELC |
Celcuity Inc. |
0 |
0.38% |
|
|
|
|
|
N/A |
0.00% |
221.86% |
61.28% |
|---|
| RNAC |
Cartesian Therapeutics, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
1,287.15% |
16.30% |
|---|
| TBPH |
Theravance Biopharma, Inc. |
0 |
0.37% |
|
|
|
|
|
N/A |
0.00% |
142.55% |
37.83% |
|---|
| ARCT |
Arcturus Therapeutics Holdings Inc. |
0 |
0.35% |
|
|
|
|
|
N/A |
0.00% |
86.41% |
44.63% |
|---|
| URGN |
UroGen Pharma Ltd. |
0 |
0.35% |
|
|
|
|
|
N/A |
0.00% |
72.43% |
4.19% |
|---|
| AURA |
Aura Biosciences, Inc. |
0 |
0.32% |
|
|
|
|
|
N/A |
0.00% |
629.76% |
48.70% |
|---|
| ANAB |
AnaptysBio, Inc. |
0 |
0.32% |
|
|
|
|
|
N/A |
0.00% |
81.07% |
8.54% |
|---|
| ZBIO |
ProShares UltraPro Short Nasdaq Biotechn... |
|
0.29% |
|
|
|
|
|
N/A |
0.00% |
N/A |
N/A |
|---|
| YMAB |
Y-mAbs Therapeutics, Inc. |
0 |
0.27% |
|
|
|
|
|
N/A |
0.00% |
986.78% |
48.05% |
|---|
| OLMA |
Olema Pharmaceuticals, Inc. |
0 |
0.25% |
|
|
|
|
|
N/A |
0.00% |
N/A |
44.40% |
|---|
| SLRN |
ACELYRIN Inc. |
|
0.24% |
|
|
|
|
|
|
|
|
|
|---|
| ALDX |
Aldeyra Therapeutics, Inc. |
0 |
0.23% |
|
|
|
|
|
N/A |
0.00% |
114.24% |
10.06% |
|---|
| RIGL |
Rigel Pharmaceuticals, Inc. |
0 |
0.23% |
|
|
|
|
|
N/A |
0.00% |
115.07% |
27.50% |
|---|
| RZLT |
Rezolute, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
253.88% |
24.82% |
|---|
| VNDA |
Vanda Pharmaceuticals Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
76.78% |
32.75% |
|---|
| ITOS |
iTeos Therapeutics, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
1,421.95% |
5.60% |
|---|
| AMLX |
Amylyx Pharmaceuticals, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
76.16% |
47.26% |
|---|
| CMPS |
COMPASS Pathways plc |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
189.13% |
46.51% |
|---|
| LRMR |
Larimar Therapeutics, Inc. |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
191.58% |
34.05% |
|---|
| ELDN |
Eledon Pharmaceuticals, Inc. |
0 |
0.19% |
|
|
|
|
|
N/A |
0.00% |
209.06% |
35.92% |
|---|
| FDMT |
4D Molecular Therapeutics, Inc. |
0 |
0.19% |
|
|
|
|
|
N/A |
0.00% |
352.62% |
90.18% |
|---|
|
Cash and Equivalents |
|
0.19% |
|
|
|
|
|
|
|
|
|
|---|
| PROK |
ProKidney Corp. |
0 |
0.18% |
|
|
|
|
|
N/A |
0.00% |
189.86% |
2.37% |
|---|
| ZNTL |
Zentalis Pharmaceuticals, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
248.45% |
21.38% |
|---|
| MGNX |
MacroGenics, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
276.85% |
28.64% |
|---|
| ACRS |
Aclaris Therapeutics, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
367.80% |
65.93% |
|---|
| ALEC |
Alector, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
189.51% |
0.37% |
|---|
| KYTX |
Kyverna Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
452.69% |
46.66% |
|---|
| STRO |
Sutro Biopharma, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
404.46% |
46.49% |
|---|
| ENTA |
Enanta Pharmaceuticals, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
N/A |
20.59% |
|---|
| 1835589D |
Chinook Therapeutics Inc. |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|